Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services, providing an unparalleled, ...

Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces its pioneering efforts to develop technology in the field of Spatial Surgery - a revolutionary new frontier in ...

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature handheld robotics and digital solutions for hip, knee and shoulder in addition to innovative ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Smith & Nephew received FDA 510(k) clearance of a ...

(Reuters) - Smith+Nephew said on Thursday revenue recovered strongly in the third quarter from the second, as hospitals managed to carry out more elective surgeries after the initial wave of ...

Please provide your email address to receive an email when new articles are posted on . Smith & Nephew announced a co-marketing agreement for the OrthoSonic 3D surgery planning technology from ...